Back to the NewsWire

Patientgain

Published September 7, 2026

Marketing For TMS, Ketamine and Spravato + HIPAA Compliant - PatientGain

Marketing IV ketamine as “FDA-approved for depression” violates federal law and can result in severe legal penalties or clinic shutdown. Ad Platform.

Read the full story at Patientgain

Surfaced by this Google Alert

  • Ketamine